OptumRx PA criteria for Zepbound Standard OptumRx PA for Zepbound (obesity indication) typically requires: BMI 30 or higher, or BMI 27 with documented comorbidity (hypertension, type 2 diabetes, dyslipidemia, OSA) Participation in a structured weight-management program, typically 3 to 6 months of documented engagement Absence of contraindications (personal or family history of MTC, MEN 2) Attestation of medical necessity by the prescribing physician For step-therapy plans, prior trial of preferred GLP-1 alternative Initial approval is generally 6 months, with reauthorization requiring documented weight loss of 5% or more from baseline
Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations
Some may notice changes in skin texture and hydration within 12 weeks, but collagen remodeling and deeper changes may take 412 weeks with consistent use
Others require continuous higher-dose therapy to prevent regain
And of course, you know, WeightWatchers and others in this industry have been leading the charge that willpower is the solution to the disease of obesity," Dr